Original Research

Published on 12 Apr 2022

Oncolytic Activity of a Chimeric Influenza A Virus Carrying a Human CTLA4 Antibody in Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Hao Yang
Guanglin Lei
Fang Sun
Jinxia Cheng
Jin Yan
Shaogeng Zhang
Penghui Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.875525

2,800 views
6 citations

Original Research

Published on 11 Apr 2022

TGF-β1 Promotes Autophagy and Inhibits Apoptosis in Breast Cancer by Targeting TP63

in Pharmacology of Anti-Cancer Drugs

Yichao Wang
Hongsheng Lu
Zhongrong Wang
Yueguo Li
Xiaoying Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.865067

3,030 views
9 citations

Original Research

Published on 11 Apr 2022

A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer

in Pharmacology of Anti-Cancer Drugs

Stefania Zuppone
Chiara Assalini
Claudia Minici
Oronza A. Botrugno
Flavio Curnis
Massimo Degano
Angelo Corti
Francesco Montorsi
Andrea Salonia
Riccardo Vago

Frontiers in Oncology

doi 10.3389/fonc.2022.846958

2,119 views
4 citations

Original Research

Published on 08 Apr 2022

Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling

in Pharmacology of Anti-Cancer Drugs

Jiahui Wu
Xiao He
Ziwei Xiong
Lingyu Shi
Daofeng Chen
Yulin Feng
Quan Wen

Frontiers in Oncology

doi 10.3389/fonc.2022.855603

2,582 views
5 citations

Original Research

Published on 08 Apr 2022

CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma

in Pharmacology of Anti-Cancer Drugs

Ran Sun
Xuemei Wang
Leichao Zhang
Yu Gu
Shaojuan Yang
Liping Wang
Xueju Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.819003

2,057 views
2 citations

Original Research

Published on 07 Apr 2022

LncRNA HCG11 Facilitates Nasopharyngeal Carcinoma Progression Through Regulating miRNA-490-3p/MAP3K9 Axis

in Pharmacology of Anti-Cancer Drugs

Jian Zheng
Zhuochen Zhao
Huijun Ren
Yongfeng Wang
Xianchun Meng
Wenjing Zhang
Cai Zhang
Liang Ming
Xiubo Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.872033

3,285 views
9 citations

Original Research

Published on 07 Apr 2022

Mechanism of Phellodendron and Anemarrhena Drug Pair on the Treatment of Liver Cancer Based on Network Pharmacology and Bioinformatics

in Pharmacology of Anti-Cancer Drugs

Xiaofeng Ruan
Wenyuan Li
Peng Du
Yao Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.838152

4,101 views
7 citations

Original Research

Published on 06 Apr 2022

Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab–Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study

in Pharmacology of Anti-Cancer Drugs

Rosalba D’Alessandro
Maria Grazia Refolo
Annalisa Schirizzi
Giampiero De Leonardis
Rossella Donghia
Vito Guerra
Gianluigi Giannelli
Ivan Roberto Lolli
Maria Maddalena Laterza
Ferdinando De Vita

Frontiers in Oncology

doi 10.3389/fonc.2022.862116

2,393 views
3 citations

Original Research

Published on 04 Apr 2022

LncRNA ENST869 Targeting Nestin Transcriptional Region to Affect the Pharmacological Effects of Chidamide in Breast Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Xiuyan Feng
Han Han
Yarui Guo
Xue Feng
Shanchun Guo
Weiqiang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.874343

1,948 views
2 citations

Original Research

Published on 31 Mar 2022

The Incidence of Cancer Is Increased in Hospitalized Adult Patients With Obstructive Sleep Apnea in China: A Retrospective Cohort Study

in Pharmacology of Anti-Cancer Drugs

Hailin Xiong
Miaochan Lao
Longlong Wang
Yanxia Xu
Guo Pei
Bin Lu
Qianping Shi
Jialian Chen
Shuyi Zhang
Qiong Ou

Frontiers in Oncology

doi 10.3389/fonc.2022.856121

3,490 views
5 citations

Original Research

Published on 30 Mar 2022

Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim–Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Shaopu Hu
Mengxue Ge
Shuixiu Zhang
Min Jiang
Kaiwen Hu
Lei Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.854596

4,207 views
7 citations

Original Research

Published on 29 Mar 2022

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients

in Pharmacology of Anti-Cancer Drugs

Lifeng Chen
Bo Tian
Wen Liu
Haitao Liang
Yong You
Weizhen Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.855674

6,072 views
4 citations

Review

Published on 29 Mar 2022

Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges

in Pharmacology of Anti-Cancer Drugs

Vivek P. Chavda
Aayushi B. Patel
Kavya J. Mistry
Suresh F. Suthar
Zhuo-Xun Wu
Zhe-Sheng Chen
Kaijian Hou

Frontiers in Oncology

doi 10.3389/fonc.2022.867655

12,834 views
64 citations

Original Research

Published on 28 Mar 2022

Propofol Inhibits Proliferation and Augments the Anti-Tumor Effect of Doxorubicin and Paclitaxel Partly Through Promoting Ferroptosis in Triple-Negative Breast Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Chen Sun
Pan Liu
Lijian Pei
Mengyun Zhao
Yuguang Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.837974

5,852 views
21 citations

Original Research

Published on 25 Mar 2022

Transient Receptor Potential Cation Channel Subfamily V Member 1 Expression Promotes Chemoresistance in Non-Small-Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Li Li
Cheng Chen
Qin Xiang
Songqing Fan
Tian Xiao
Yangchao Chen
Duo Zheng

Frontiers in Oncology

doi 10.3389/fonc.2022.773654

3,468 views
15 citations

Original Research

Published on 22 Mar 2022

Gracillin Shows Potential Efficacy Against Non-Small Cell Lung Cancer Through Inhibiting the mTOR Pathway

in Pharmacology of Anti-Cancer Drugs

Yamei Li
Hai Liu
Xiaoxuan Liu
Bang Xiao
Minhong Zhang
Yaoling Luo
Mingchun Li
Jianqiong Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.851300

2,984 views
9 citations

Navigation group

Articles

Oncolytic Activity of a Chimeric Influenza A Virus Carrying a Human CTLA4 Antibody in Hepatocellular Carcinoma

TGF-β1 Promotes Autophagy and Inhibits Apoptosis in Breast Cancer by Targeting TP63

A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer

Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling

CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma

LncRNA HCG11 Facilitates Nasopharyngeal Carcinoma Progression Through Regulating miRNA-490-3p/MAP3K9 Axis

Mechanism of Phellodendron and Anemarrhena Drug Pair on the Treatment of Liver Cancer Based on Network Pharmacology and Bioinformatics

Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab–Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study

LncRNA ENST869 Targeting Nestin Transcriptional Region to Affect the Pharmacological Effects of Chidamide in Breast Cancer Cells

The Incidence of Cancer Is Increased in Hospitalized Adult Patients With Obstructive Sleep Apnea in China: A Retrospective Cohort Study

Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim–Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients

Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges

Propofol Inhibits Proliferation and Augments the Anti-Tumor Effect of Doxorubicin and Paclitaxel Partly Through Promoting Ferroptosis in Triple-Negative Breast Cancer Cells

Transient Receptor Potential Cation Channel Subfamily V Member 1 Expression Promotes Chemoresistance in Non-Small-Cell Lung Cancer

Gracillin Shows Potential Efficacy Against Non-Small Cell Lung Cancer Through Inhibiting the mTOR Pathway